Abstract 4525: mTOR complex inhibition as a novel therapeutic strategy in high-grade papillary serous ovarian cancer

2014 ◽  
Author(s):  
Fernanda Musa ◽  
Amandine Alard ◽  
Gizelka David-West ◽  
Iulia Giuroiu ◽  
Stephanie Blank ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Therapeutic Strategy ◽  
High Grade ◽  
Serous Ovarian Cancer ◽  
Novel Therapeutic

mTOR complex inhibition as a novel therapeutic strategy in high-grade papillary serous ovarian cancer

2014 ◽  
Vol 133 ◽  
pp. 119-120
Author(s):  
F. Musa ◽  
A. Alard ◽  
S.V. Blank ◽  
B. Pothuri ◽  
J.P. Curtin ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Therapeutic Strategy ◽  
High Grade ◽  
Serous Ovarian Cancer ◽  
Novel Therapeutic

Abstract number 14: mTOR complex inhibition as a novel therapeutic strategy in high grade papillary serous ovarian cancer

2014 ◽  
Vol 134 (2) ◽  
pp. 434-435
Author(s):  
F. Musa ◽  
A. Alard ◽  
S. Blank ◽  
B. Pothuri ◽  
J. Curtin ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Therapeutic Strategy ◽  
High Grade ◽  
Serous Ovarian Cancer ◽  
Novel Therapeutic

scholarly journals 416 Elucidating resistance mechanism to parp inhibitors for the development of novel therapeutic approaches in high-grade serous ovarian cancer

2020 ◽  
Author(s):  
Hagen Kulbe ◽  
Wanja Kassuhn ◽  
Frauke Ringel ◽  
Gabriele Welsch ◽  
Peggy Treffkorn ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Resistance Mechanism ◽  
Parp Inhibitors ◽  
High Grade ◽  
Serous Ovarian Cancer ◽  
Therapeutic Approaches ◽  
Novel Therapeutic

scholarly journals Abstract LB-054: FKBPL as a novel therapeutic target and prognostic biomarker in high grade serous ovarian cancer

2018 ◽  
Author(s):  
Stephanie Annett ◽  
Gillian Moore ◽  
Amy Short ◽  
Neermeen Moustafa ◽  
Sudipto Das ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Therapeutic Target ◽  
Prognostic Biomarker ◽  
High Grade ◽  
Serous Ovarian Cancer ◽  
Novel Therapeutic

Abstract B58: Connective tissue growth factor (CTGF) as a novel therapeutic target in high grade serous ovarian cancer

2013 ◽  
Author(s):  
Kim Moran-Jones ◽  
Rajmohan Murali ◽  
David K. Chang ◽  
Carol W. Wong ◽  
Suzanne M. Spong ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Growth Factor ◽  
Connective Tissue ◽  
Connective Tissue Growth Factor ◽  
Therapeutic Target ◽  
Tissue Growth ◽  
High Grade ◽  
Serous Ovarian Cancer ◽  
Novel Therapeutic

scholarly journals 290 Targeting AKT and DNA-PK as a therapeutic strategy in platinum resistant high-grade serous ovarian cancer

2020 ◽  
Author(s):  
Natasha Rinne ◽  
Shengnan Yuan ◽  
Christina Fotopoulou ◽  
Hani Gabra ◽  
Paula Cunnea
Keyword(s):  
Ovarian Cancer ◽  
Therapeutic Strategy ◽  
High Grade ◽  
Serous Ovarian Cancer ◽  
Platinum Resistant

EP964 Targeting AKT and DNA-PK as a therapeutic strategy in platinum resistant high-grade serous ovarian cancer

2019 ◽  
Author(s):  
N Rinne ◽  
E Curry ◽  
C Fotopoulou ◽  
H Gabra ◽  
P Cunnea
Keyword(s):  
Ovarian Cancer ◽  
Therapeutic Strategy ◽  
High Grade ◽  
Serous Ovarian Cancer ◽  
Platinum Resistant

scholarly journals Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer

Oncotarget ◽  
2015 ◽  
Vol 6 (42) ◽  
pp. 44551-44562 ◽  
Author(s):  
Kim Moran-Jones ◽  
Brian S. Gloss ◽  
Rajmohan Murali ◽  
David K. Chang ◽  
Emily K. Colvin ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Growth Factor ◽  
Connective Tissue ◽  
Connective Tissue Growth Factor ◽  
Therapeutic Target ◽  
Tissue Growth ◽  
High Grade ◽  
Serous Ovarian Cancer ◽  
Novel Therapeutic

scholarly journals TARGETING AKT AND DNA-PK AS A THERAPEUTIC STRATEGY IN PLATINUM RESISTANT HIGH-GRADE SEROUS OVARIAN CANCER.

2020 ◽  
Author(s):  
Natasha Rinne ◽  
Shengnan Yuan ◽  
Christina Fotopoulou ◽  
Paula Cunnea
Keyword(s):  
Ovarian Cancer ◽  
Therapeutic Strategy ◽  
High Grade ◽  
Serous Ovarian Cancer ◽  
Platinum Resistant
Sign in / Sign up

Export Citation Format

Share Document